What are the consequences of failing to comply with the sequence rules in patent applications?

Source: FAQ (MPEP-Based)BlueIron Update: 2024-09-29

This page is an FAQ based on guidance from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth sources. This is information only: it is not legal advice.

Failing to comply with the sequence rules in patent applications can have serious consequences. According to MPEP 2412.01:

“Applications that are not in compliance with the sequence rules will be treated in accordance with the pertinent sections of the MPEP. Patent applications filed on or after December 18, 2013, failing to comply with the requirements of 37 CFR 1.821 – 1.825 will not be accorded a filing date until all biotechnology sequence requirements are met.”

This means that:

  • Applications may not receive a filing date until all sequence requirements are met
  • Examiners may issue notices to comply, which could delay prosecution
  • In extreme cases, non-compliance could result in abandonment of the application

It’s crucial for applicants to ensure full compliance with the sequence rules to avoid these potential setbacks in the patent application process.

Topics: MPEP 2400 - Biotechnology MPEP 2412.01 - Overview Of The Sequence Rules Patent Law Patent Procedure
Tags: Sequence Format